Clinical trial

Innovations in HIV Testing (TI)

NCT03271424

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-10-01

PhaseNA

Study timeline

Study start (actual)2015-10-01Date precision: day

Registry last updated2018-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Human Immunodeficiency Virusunresolved

Interventions

Oraquick HIV Self Test - ChoiceDIAGNOSTIC_TEST

Atomo HIV Self Test - ChoiceDIAGNOSTIC_TEST

Oraquick HIV Self Test and Atomo HIV Self Test - BothDIAGNOSTIC_TEST

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

University of Witwatersrand, South Africacollaborator

University of California, San Franciscocollaborator

National Institutes of Health (NIH)collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03271424 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.